Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Bassano Del Grappa

9 clinical trials in Bassano Del Grappa, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Bassano Del Grappa at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Bassano Del Grappa

Open in trial search

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study on Surgical Treatment with or without Apalutamide for Patients with High-Risk Prostate Cancer Eligible for Radical Prostatectomy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Universita' Degli Studi Di Torino
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia

Study on Long-Term Safety and Tolerability of Iptacopan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Study on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Danicopan
  • Sponsor:Alexion Pharmaceuticals Inc.

Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Danazol
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Prostate cancer

Not recruiting

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Bassano Del Grappa

What the registry says about research in the country

01 Kidney and Blood Pressure Research

Innovative studies exploring combination therapies for patients with chronic kidney disease and hypertension, focusing on improving clinical outcomes and renal function preservation.

  • Kidney function preservation
  • Blood pressure management
  • Cardiovascular protection

Evaluating novel therapeutic approaches to reduce kidney failure risk and improve patient outcomes.

02 Hematological Disorders

Advanced research into blood disorders including Paroxysmal Nocturnal Hemoglobinuria and Immune Thrombocytopenia, testing new therapeutic agents for better disease management.

  • Blood disorder treatments
  • Immune system modulation
  • Long-term disease control

Multiple trials evaluating novel medications for rare blood conditions and autoimmune disorders.

03 Oncology Research

Groundbreaking studies in prostate cancer and metastatic colorectal cancer, investigating targeted therapies and combination treatments.

  • Cancer treatment optimization
  • Hormone therapy evaluation
  • Targeted therapeutic approaches

Focusing on improving treatment outcomes through personalized medicine approaches and innovative drug combinations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.